Most Read Articles

Viewssort iconArticle
563R. Scott Kennedy Awarded the 2008 El-Hibri Peace Education Prize
196Emergent Biosolutions Announces Dr. Stephen Lockhart Joins Company To Lead Commercial Product Development Subsidiary
156Oxford-Emergent Tuberculosis Consortium Signs Commercial License Agreement with Vivalis to Explore Production Of MVA85A TB Vacci
91Emergent Biosolutions Receives Development Contract From Niaid/Barda To Fund Continued Development Of Anthrax Therapeutic
75Emergent BioSolutions Announces That BioThrax (Anthrax Vaccine Adsorbed) Receives Market Authorization in India
70Emergent Biosolutions Announces Management Changes
64Emergent BioSolutions Enhances Manufacturing Infrastructure with Strategic Acquisition in Baltimore
58Emergent BioSolutions hands out bonuses
55Lebanese CEO Sees Opportunity in Current Crisis
54Former Dhhs Secretary, Dr. Louis W. Sullivan, Joins Board Of Directors Of Emergent Biosolutions
52Fuad el-Hibri, king of anthrax, wins an award from Ernst & Young
52Emergent BioSolutions Buys Rival Vaccine for $2 Million
51Fuad El-Hibri on Twine
49Emergent BioSolutions Inc. (EBS) CEO & Chairman, 10% Owner Fuad El-hibri sells 15,000 Shares
49Fuad El-Hibri Ernst & Young Entrepreneur of the Year
49Emergent biosolutions announces that department OF HEALTH AND HUMAN SERVICES AND DEPARTMENT OF DEFENSE ISSUED NOTICES OF INTENT
47Emergent Biosolutions Expands Presence In Germany
47STATEMENT BY FUAD EL-HIBRI, EMERGENT BIOSOLUTIONS CHAIRMAN AND CHIEF EXECUTIVE OFFICER, ON THE PASSING OF ADMIRAL WILLIAM CROWE,
46EMERGENT BIOSOLUTIONS ANTICIPATES 2ND QUARTER BIOTHRAX REVENUES OF APPROXIMATELY $20 MILLION BASED ON ACCELERATED DELIVERY TO DE
45Maker of anthrax vaccine discusses challenges of marketing overseas
44October 9, 2008 - Farr Honors Former Santa Cruz Mayor
42Joe M. Allbaugh, Former Fema Director, Joins Emergent Biosolutions’ Board Of Directors
42Fuad El-Hibri on Wikipedia
42U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES REMAINS COMMITTED TO PROCUREMENT OF BIOTHRAX® UNDER CURRENT CONTRACT
42EMERGENT BIOSOLUTIONS ANNOUNCES EXPANSION OF BOARD OF DIRECTORS AND APPOINTMENT OF DR. SUE BAILEY TO THE COMPANY’S BOARD OF DIRE
42Washington Launched Me, But I am Proud to be a Lebanese Dreaming of New Technology - Al Anwar
41Fuad El-Hibri on Businessweek
40Ernst & Young’s Entrepreneur of the Year Fuad El-Hibri
40 Emergent BioSolutions reacts to BARDA's Request for Proposal cancellation
40Fued El-Hibri Profile on Forbes
39EMERGENT BIOSOLUTIONS’ TYPHOID VACCINE CANDIDATE ACHIEVES ENDPOINTS IN PHASE II CLINICAL STUDY
39Emergrnt Biosultions on Answers.com
38<a href="http://www.muckety.com/Fuad-El-Hibri/8838.muckety">Fuad El-
38Fuad El-Hibri on Webbiographies
37Rene Moawad Foundation (RMF) USA Holds 14th Annual Washington Gala Dinner
36EMERGENT BIOSOLUTIONS SIGNS $448 MILLION THREE YEAR CONTRACT WITH DEPARTMENT OF HEALTH AND HUMAN SERVICES
36Emergent BioSolutions Inc., Q2 2009 Earnings Call Transcript
35Emergent looks to buy Maryland lab
35EMERGENT BIOSOLUTIONS ANNOUNCES MANAGEMENT CHANGES
34Fuad El-Hibri on Social Networks
34Board expands with Election of Fuad El-Hibri
33U.S. Government To Purchase Additional 14.5 Million Doses Of Biothrax® Under New Contract Valued At Up To $404 Million
33Jerome M. Hauer Named To Board Of Directors Of Emergent Biosolutions
33EMERGENT BIOSOLUTIONS ANNOUNCES THE APPOINTMENT OF DENISE LANDRY AS SENIOR VICE PRESIDENT, QUALITY
32Emergent Biosolutions Acquires Monoclonal Anthrax Product Candidate
31Emergent BioSolutions Chairman and CEO, Mr. Fuad El-Hibri, Named Ernst &amp; Young Entrepreneur of the Year 2009 Award Winner in
31Emergent BioSolutions Chairman and CEO, Mr. Fuad El-Hibri, Named Ernst &amp; Young Entrepreneur of the Year 2009 Award Finalist
31Emergent Biosolutions Delivers Over 3 Million Doses Of Biothrax® To U.S. Department Of Health And Human Services For Strategic N
30Fuad El-Hibri Profiles
30About Fuad El-Hibri on Atlanta Business Chronicle
29Fuad El-Hibri Earnings Call
27Fuad El-Hibri El-Hibri Peace Education Prize
26EMERGENT BIOSOLUTIONS ANNOUNCES RESULTS FROM ANNUAL MEETING OF STOCKHOLDERS
25Digg Fuad El-Hibri
25Emergent Biosolutions El-Hibri
25Fuad El-Hibri’s Linkedin Profile
25Bad News Clouds Two Bio Defense Stocks
24Emergent BioSolutions To Acquire Protein Sciences’ Phase III Recombinant Flu Vaccine Candidate, FluBlok(R), And Related Novel Pl
24New TB Vaccine Candidate Enters Phase IIb Proof-of-Concept Trial in South Africa
23Emergent BioSolutions and Ninebio Sdn. Bhd. AnnounceJoint Venture in Malaysia.
23EMERGENT BIOSOLUTIONS INC Profile on AOL
23Peace Prize awarded to Center for Nonviolence’s Kennedy
23Fuad El-Hibri is a Washington-Area Success Story
22Fuad El-Hibri on Corridor Inc.
20Emergent BioSolutions moves forward with typhoid vaccine